The 4th RAS-Targeted Drug Development Summit offers a unique opportunity to collaborate with key industry decision-makers in the RAS space.
We will work with you to build a bespoke partnership package focused on making valuable connections and generating actionable leads to ensure you meet your 2022 commercial objectives.
What Makes the RAS-Targeted Drug Development Summit Different:
Benefit from Market Intelligence
Drugging the previously undruggable RAS targets opens a tremendous opportunity to address the current unmet clinical need. Hear how and where pharmaceutical giants are looking for services and solutions to facilitate their R&D platforms and match your solutions accordingly
Raise Brand Awareness
Benefit from pre and post conference exposure to our drug discovery KOL community and increase market share through unique branding formats. Also, differentiate your discovery, pre-clinical and translational services from other solution providers
Position Yourself as an Industry Expert
With the emergence of biotech companies focused on developing mutant-targeted RAS therapies, followed by interest shown from large pharma and investors, this meeting is a dedicated platform to put your independent expertise in front of the key decision makers in the field
Meet and Network with Industry Pioneers
With a room full of drug developers looking to see how they can effectively translate their exciting early discovery efforts into safe and effective therapeutics, meet prospective clients during speed networking breaks, bespoke 1-2-1 meetings and more informal networking receptions
Generate Commercial Collaborations
Make sure your hottest prospects are in the room and part of the discussion, by having a wish-list of your choice contacted in advance of the event
Who Will You Meet?
A Snapshot of 2021 Attendees